Pharmaceutical Automation Market Size, Share, Forecast, & Trends Analysis by Offering, Mode of Automation, End User, & Geography

Description

List of Tables

The research report titled, 'Global Pharmaceutical Automation Market by Offering (Solutions and Services), Mode of Automation (Semi-automatic Systems and Fully Automatic Systems), End User (Pharmaceutical Industry and Biotech Industry), & Geography -Forecasts to 2031', provides in-depth analysis of pharmaceutical automation market across five major geographies and emphasizes on the current market trends, market sizes, market shares, recent developments, and forecasts till 2031.

The pharmaceutical automation market is projected to reach $25.11 billion by 2031, at a CAGR of 10.8% from 2024 to 2031. The growth of the global pharmaceutical automation market is fueled by the rising adoption of robots in pharmaceutical manufacturing, government initiatives to support industrial automation, and increasing demand for energy-efficient systems. However, the high capital expenditure (CAPEX) required may hinder market growth.

Furthermore, the rising demand for IIoT in pharmaceutical manufacturing is expected to generate growth opportunities for the stakeholders in this market. However, the lack of availability of a skilled workforce and cybersecurity risk associated with automated systems is a major challenge impacting the market growth.

Based on offering, the pharmaceutical automation market is segmented into solutions and services. In 2024, the solutions segment is expected to account for a larger share of 87.5% of the global pharmaceutical automation market. The segment's large share is due to the increasing demand for automation to ensure high-quality and reliable manufacturing, the rising need for real-time monitoring and predictive maintenance capabilities, and the growing need for operational efficiency while reducing operational costs and downtime.

Furthermore, the solutions segment is poised to register a higher CAGR during the forecast period.

Based on mode of automation, the pharmaceutical automation market is segmented into semi-automatic systems and fully automatic systems. In 2024, the semi-automatic systems segment is expected to account for a larger share of 57.4% of the global pharmaceutical automation market. The segment's large share is due to the effectiveness of semi-automatic systems in streamlining processes while still enabling human oversight. This balance is essential for maintaining quality control in the pharmaceutical industry.

However, the fully automatic systems segment is anticipated to register a higher CAGR during the forecast period. The growth of this segment is attributed to growing adoption of fully automatic systems by large scale companies to increase their throughput volumes by automating the feeding and assembly processes.

Based on end user, the pharmaceutical automation market is segmented into the pharmaceutical industry and the biotech industry. In 2024, the pharmaceutical industry segment is expected to account for a larger share of 61.7% of the global pharmaceutical automation market. The segment's large share is due to the increasing need for automation in manufacturing facilities, the enforcement of stringent regulations in the pharmaceutical industry, the integration of advanced technologies such as machine vision, spectroscopy, and chromatography in inspection systems, and the growing application of AI technology in pharmaceutical manufacturing.

Furthermore, the pharmaceutical industry segment is projected to register the highest CAGR during the forecast period.

Based on geography, the pharmaceutical automation market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, Europe is expected to account for the largest share of 32.9% of the global pharmaceutical automation market. The region's large share is due to the rising digitalization and adoption of Industry 4.0 technologies in the pharmaceutical industry to improve efficiency, reduce waste, and enhance product quality, the increasing need to enhance production through automation and intelligent process technologies, and the growing demand for pharmaceutical automation.

However, Asia-Pacific is poised to register the highest CAGR of 11.8% during the forecast period. The growth of this regional market is driven by pharmaceutical companies' increasing focus on expanding manufacturing facilities, increasing investments in innovative technologies, and advancements in robotics & automation.

Key Players:

Some of the key players operating in the pharmaceutical automation market are Siemens AG (Germany), Emerson Electric (U.S.), Mitsubishi Electric Corporation (Japan), ABB Ltd (Switzerland), FANUC CORPORATION (Japan), Honeywell International Inc. (U.S.), KUKA AG (Germany), Schneider Electric SE (France), Rockwell Automation, Inc. (U.S.), YASKAWA Electric Corporation (Japan), Yokogawa Electric Corporation (Japan), General Electric Company (U.S.), OMRON Corporation (Japan), Advantech Co., Ltd. (Taiwan), and Fuji Electric Co., Ltd. (Japan).

Key questions answered in the report-

Which are the high-growth market segments based on offering, mode of automation, and end user?
What was the historical market for pharmaceutical automation?
What are the market forecasts and estimates for the period 2024-2031?
What are the major drivers, restraints, and opportunities in the pharmaceutical automation market?
Who are the major players in the pharmaceutical automation market?
What is the competitive landscape like?
What are the recent developments in the pharmaceutical automation market?
What are the different strategies adopted by the major players in the pharmaceutical automation market?
What are the key geographic trends, and which are the high-growth countries?
Who are the emerging players in the global pharmaceutical automation market, and how do they compete with the other players?

Scope of the Report:

Pharmaceutical Automation Market Assessment-by Offering

Solutions
- Enterprise-level Controls
Product Lifecycle Management (PLM)
Enterprise Resource Planning (ERP)
Manufacturing Execution Systems (MES)
- Plant Instrumentation
Motors & Drives
Robots
Articulated Robots
Cartesian Robots
SCARA
Collaborative Robots
Other Robots
Sensors
Machine Vision Systems
Cameras
Optics and LED Lighting
Relays & Switches
Other Plant Instrumentation Solutions
- Plant-level Controls
Supervisory Control and Data Acquisition (SCADA)
Distributed Control Systems (DCS)
Programmable Logic Controllers (PLC)
Other Plant-level Controls
Services
- Integration & Installation Services
- Maintenance & Support Services
- Advisory, Training, & Consulting Services
- Safety & Security Services

Pharmaceutical Automation Market Assessment-by Mode of Automation

Semi-automatic Systems
Fully Automatic Systems

Pharmaceutical Automation Market Assessment-by End User

Pharmaceutical Industry
Biotech Industry

Pharmaceutical Automation Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- Italy
- Netherlands
- Sweden
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Rest of Middle East & Africa

Product Code: MRSE - 104594

1. Introduction

1.1. Market Definition & Scope
1.2. Currency & Limitations
- 1.2.1. Currency
- 1.2.2. Limitations

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation Process
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews With Key Opinion Leaders From the Industry
2.3. Market Sizing And Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

3.1. Overview
3.2. Market Analysis, by Offering
3.3. Market Analysis, by Mode of Automation
3.4. Market Analysis, by End User
3.5. Market Analysis, by Geography
3.6. Competitive Analysis

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
- 4.2.1. Increasing Adoption of Robots in Pharmaceutical Manufacturing Driving Market Growth
- 4.2.2. Government Initiatives to Promote Industrial Automation Supporting the Growth of the Pharmaceutical Automation Market
- 4.2.3. Rising Demand for Energy-Efficient Systems Accelerating Market Expansion
- 4.2.4. High Capex Requirements Restraining Market Growth
- 4.2.5. Rising Demand for Industrial IoT in Pharmaceutical Manufacturing Generating Market Growth Opportunities
- 4.2.6. Cybersecurity Risks Associated With Automated Systems Expected to Remain A Challenge for Market Players
- 4.2.7. Shortage of Skilled Workers Hampering the Adoption of Automated Systems
4.3. Impact of AI And Blockchain Technologies On Pharmaceutical Manufacturing
4.4. Role of 5G Technology in Pharmaceutical Automation
4.5. Value Chain Analysis
- 4.5.1. Raw Material Providers
- 4.5.2. Hardware & Software Developers
- 4.5.3. Plant Instrumentation
- 4.5.4. Plant-Level Controls
- 4.5.5. Enterprise-Level Controls
- 4.5.6. System Integrators

5. Pharmaceutical Automation Market Assessment-by Offering

5.1. Overview
5.2. Solutions
- 5.2.1. Enterprise-Level Controls
  - 5.2.1.1. Enterprise Resource Planning (ERP)
  - 5.2.1.2. Product Lifecycle Management (PLM)
  - 5.2.1.3. Manufacturing Execution Systems (MES)
- 5.2.2. Plant Instrumentation
  - 5.2.2.1. Sensors
  - 5.2.2.2. Robots
    - 5.2.2.2.1. Articulated Robots
    - 5.2.2.2.2. Cartesian Robots
    - 5.2.2.2.3. Selective Compliance Assembly Robot Arms (SCARA)
    - 5.2.2.2.4. Collaborative Robots
    - 5.2.2.2.5. Other Robots
  - 5.2.2.3. Motors & Drives
  - 5.2.2.4. Machine Vision Systems
    - 5.2.2.4.1. Cameras
    - 5.2.2.4.2. Optics And LED Lighting
  - 5.2.2.5. Relays & Switches
  - 5.2.2.6. Other Plant Instrumentation Solutions
- 5.2.3. Plant-Level Controls
  - 5.2.3.1. Programmable Logic Controllers (PLC)
  - 5.2.3.2. Distributed Control Systems (DCS)
  - 5.2.3.3. Supervisory Control And Data Acquisition (SCADA)
  - 5.2.3.4. Other Plant-Level Controls
5.3. Services
- 5.3.1. Integration & Installation Services
- 5.3.2. Maintenance & Support Services
- 5.3.3. Advisory, Training, And Consulting Services
- 5.3.4. Safety & Security Services

6. Pharmaceutical Automation Market Assessment-by Mode of Automation

6.1. Overview
6.2. Semi-Automatic Systems
6.3. Fully Automatic Systems

7. Pharmaceutical Automation Market Assessment-by End User

7.1. Overview
7.2. Pharmaceutical Industry
7.3. Biotech Industry

8. Pharmaceutical Automation Market Assessment-by Geography

8.1. Overview
8.2. Europe
- 8.2.1. Germany
- 8.2.2. U.K.
- 8.2.3. Italy
- 8.2.4. Netherlands
- 8.2.5. Sweden
- 8.2.6. France
- 8.2.7. Spain
- 8.2.8. Rest of Europe
8.3. Asia-Pacific
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Japan
- 8.3.4. South Korea
- 8.3.5. Singapore
- 8.3.6. Rest of Asia-Pacific
8.4. North America
- 8.4.1. U.S.
- 8.4.2. Canada
8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Rest of Latin America
8.6. Middle East & Africa
- 8.6.1. South Africa
- 8.6.2. UAE
- 8.6.3. Saudi Arabia
- 8.6.4. Rest of the Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Industry Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

10.1. Siemens AG
10.2. Emerson Electric Co.
10.3. Mitsubishi Electric Corporation
10.4. ABB Ltd
10.5. FANUC CORPORATION
10.6. Honeywell International Inc.
10.7. KUKA AG
10.8. Schneider Electric SE
10.9. Rockwell Automation, Inc.
10.10. Yaskawa Electric Corporation
10.11. Yokogawa Electric Corporation
10.12. General Electric Company
10.13. OMRON Corporation
10.14. Advantech Co., Ltd.
10.15. Fuji Electric Co., Ltd.

11. Appendix

11.1. Available Customization
11.2. Related Reports